Condition:   Adrenocortical Carcinoma
Intervention:   Drug: Dovitinib
Sponsors:   Spanish Oncology Genito-Urinary Group;   Spanish Oncology Genito-Urinary Group
Not yet recruiting - verified January 2012

Condition:   Uterine Cervical Dysplasia
Intervention:   Drug: sodium bicarbonate buffered lidocaine
Sponsors:   Washington University School of Medicine;   Washington University School of Medicine
Recruiting - verified October 2011

Condition:   Adrenal Cortex Neoplasms
Intervention:   Drug: Axitinib
Sponsors:   National Institutes of Health Clinical Center (CC);   National Cancer Institute (NCI);   Pfizer Pharmaceuticals, Inc.
Recruiting - verified July 2011

Conditions:   Non-Small-Cell Lung Carcinoma;   Liver Cancer;   Adrenal Cancer
Intervention:   Radiation: stereotactic body radiation therapy
Sponsors:   Wake Forest University;   Wake Forest University
Recruiting - verified October 2011

Conditions:   Breast Cancer;   Lung Cancer;   Renal Cancer;   Adrenal Cancer
Intervention:   Drug: F-18 Paclitaxel (FPAC)
Sponsors:   National Institutes of Health Clinical Center (CC);   National Cancer Institute (NCI)
Not yet recruiting - verified September 2011

Condition:   Cancer
Interventions:   Drug: hydroxychloroquine;   Drug: sunitinib malate
Sponsors:   University of Medicine and Dentistry New Jersey;   University of Medicine and Dentistry New Jersey;   National Cancer Institute (NCI)
Recruiting - verified October 2011

Conditions:   Adrenal Cortical Cancer;   Brain Cancer;   Breast Cancer;   CNS Cancer;   Colon Cancer;   HEENT Cancer;   Hodgkin's Disease;   Kaposi's Sarcoma;   Liver Cancer;   Lung Cancer;   Non-Hodgkin's Lymphoma;   Ovarian Cancer;   Pancreatic Cancer;   Prostate Cancer;   Rectal Cancer;   Renal Cancer;   Sarcoma;   Squamous Cell Carcinoma;   Thyroid Cancer
Interventions:   Device: Proton-decoupled 31P MRS at 1.5T;   Device: 1H Spectroscopy at 1.5T and 3T
Sponsors:   Memorial Sloan-Kettering Cancer Center;   Memorial Sloan-Kettering Cancer Center;   Columbia University;   University of Pennsylvania;   St.George's Hospital (England);   Royal Marsden NHS Foundation Trust;   University Medical Center Nijmegen;   Weill Medical College of Cornell University
Recruiting - verified February 2012

Condition:   Adrenocortical Carcinoma
Interventions:   Biological: filgrastim;   Biological: pegfilgrastim;   Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: mitotane;   Procedure: conventional surgery
Sponsors:   National Cancer Institute (NCI);   Children's Oncology Group;   National Cancer Institute (NCI)
Recruiting - verified July 2011

Condition:   Adrenal Gland Neoplasm
Intervention:  
Sponsors:   National Institutes of Health Clinical Center (CC);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified September 2011